{
    "root": "2f987c95-695b-d900-e063-6294a90a0cf8",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Escitalopram Oral Solution",
    "value": "20250305",
    "ingredients": [
        {
            "name": "SORBITOL SOLUTION",
            "code": "8KW3E207O2"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "TRISODIUM CITRATE DIHYDRATE",
            "code": "B22547B95K"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "ESCITALOPRAM OXALATE",
            "code": "5U85DBW7LO"
        }
    ],
    "indications": "escitalopram indicated treatment : major depressive disorder ( mdd ) adults pediatric patients 12 years age older . generalized anxiety disorder ( gad ) adults . additional pediatric information approved abbvie inc. ’ lexapro ( escitalopram ) tablets lexapro ( escitalopram ) oral solution . however , due abbvie inc. ’ marketing exclusivity rights , product labeled information .",
    "contraindications": "indication population recommended mdd adults ( 2.1 ) initial : 10 mg daily recommended : 10 mg daily maximum : 20 mg daily mdd pediatric patients 12 years older ( 2.1 ) initial : 10 mg daily recommended : 10 mg daily maximum : 20 mg daily gad adults ( 2.2 ) initial : 10 mg daily recommended : 10 mg daily maximum : 20 mg daily additional benefits seen 20 mg daily ( 2.1 ) administer daily , morning evening , without food ( 2.3 ) elderly patients : recommended 10 mg daily ( 2.4 ) hepatic impairment : recommended 10 mg daily ( 2.4 , 8.6 ) discontinuing escitalopram , reduce dose gradually whenever possible ( 2.5 )",
    "warningsAndPrecautions": "supplied escitalopram oral solution , usp,5 mg/5 ml , clear , colorless liquid peppermint flavor 240 ml bottle ( 8 fluid oz ) ndc # 62135-729-37 unit dose cup 10 ml ndc # 62135-729-10 20 unit dose cups 10 ml ndc # 62135-729-24 storage handling store 20°c 25°c ( 68°f 77°f ) ; excursions permitted 15° 30°c ( 59° 86°f ) [ usp controlled room temperature ] .",
    "adverseReactions": "escitalopram contraindicated patients : taking maois escitalopram within 14 days stopping treatment escitalopram increased risk serotonin syndrome . escitalopram within 14 days stopping maoi intended treat psychiatric disorders also contraindicated [ ( 2.7 ) ( 5.2 ) ] . starting escitalopram patient treated maois linezolid intravenous methylene blue also contraindicated increased risk serotonin syndrome [ ( 2.6 ) ( 5.2 ) ] . taking pimozide [ ( 7 ) ] hypersensitivity escitalopram citalopram inactive ingredients escitalopram .",
    "indications_original": "Escitalopram is indicated for the treatment of:\n                  \n                     major depressive disorder (MDD) in adults and pediatric patients 12 years of age and older.\n                     generalized anxiety disorder (GAD) in adults.\n                  \n                  \n                     Additional pediatric use information is approved for AbbVie Inc.’s Lexapro (escitalopram) tablets and LEXAPRO (escitalopram) oral solution. However, due to AbbVie Inc.’s marketing exclusivity rights, this drug product is not labeled with that information.",
    "contraindications_original": "Indication and Population Recommended Dosage MDD in Adults ( 2.1 ) Initial: 10 mg once daily Recommended: 10 mg once daily Maximum: 20 mg once daily MDD in Pediatric Patients 12 years and older ( 2.1 ) Initial: 10 mg once daily Recommended: 10 mg once daily Maximum: 20 mg once daily GAD in Adults ( 2.2 ) Initial: 10 mg once daily Recommended: 10 mg once daily Maximum: 20 mg once daily No additional benefits were seen at 20 mg once daily ( 2.1 ) Administer once daily, morning or evening, with or without food ( 2.3 ) Elderly patients: recommended dosage is 10 mg once daily ( 2.4 ) Hepatic impairment: recommended dosage is 10 mg once daily ( 2.4 , 8.6 ) When discontinuing escitalopram, reduce dose gradually whenever possible ( 2.5 )",
    "warningsAndPrecautions_original": "How Supplied\n                  \n                  \n                     Escitalopram Oral Solution, USP,5 mg/5 mL, a clear, colorless liquid with peppermint flavor\n\n \n                  240 mL bottle (8 fluid oz)           NDC# 62135-729-37\n                  Unit Dose Cup of 10 mL             NDC # 62135-729-10\n                  20 Unit Dose Cups of 10 mL       NDC # 62135-729-24\n                  \n                  \n                     Storage and Handling\n                  \n                  Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].",
    "adverseReactions_original": "Escitalopram is contraindicated in patients:\n                  \n                     taking MAOIs with escitalopram or within 14 days of stopping treatment with escitalopram because of an increased risk of serotonin syndrome. The use of escitalopram within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated [\n  \n   see\n   \n    Dosage and Administration (2.7)and\n   \n    Warnings and Precautions (5.2)\n                        ]. Starting escitalopram in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome [\n  \n   see\n   \n    Dosage and Administration (2.6)and\n   \n    Warnings and Precautions (5.2)\n                        ].\n \n  \n                     taking pimozide [\n  \n   see\n   \n    Drug Interactions (7)]\n  \n   \n                     \n                     with a hypersensitivity to escitalopram or citalopram or any of the inactive ingredients in escitalopram."
}